Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Risky substance avoidance" refers to an individual's tendency or capacity to refrain from using potentially addictive substances. This concept represents a **protective factor**, reducing the likelihood that someone will develop substance use disorder (SUD)[4][5]. The propensity for risky substance avoidance arises from complex interactions between biological factors (such as genetics and neurobiology), psychological traits (like self-control), environmental influences, and life experiences[2][3]. While certain brain regions—most notably the prefrontal cortex—are implicated in decision-making processes that underlie this behavior, there is no single molecule or receptor responsible for "risky substance avoidance"[1]. Instead, it reflects an emergent property of multiple neural circuits involved in executive function and impulse control. As such, it cannot be classified as a therapeutic target like receptors or enzymes can be. In summary: - **Not a molecular target**, but rather describes protective behaviors/factors influencing addiction risk. - **No abbreviation**, aliases are descriptive only. - **Not suitable for structured data fields intended for molecules/receptors/genes. If you need information on specific molecules/receptors involved in these behaviors—such as dopamine receptors, serotonin transporters, CRF receptors—or want details about targets relevant to addiction biology more broadly, please specify further.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Risky substance avoidance.